Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
61°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
September 01, 2023
Tags
Europe News
Pharmaceuticals
Business News
From
CNBC.com News
5 things to know before the stock market opens Friday
September 01, 2023
Tags
MongoDB Inc
Lulu's Fashion Lounge Holdings Inc
Investment strategy
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Diabetes
Health care industry
Biotechnology
From
CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
August 25, 2023
Tags
Health care industry
Biotechnology
Companies
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
Companies
Health & Science
Weight management
From
CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
August 17, 2023
Tags
Health & Science
Breaking news
Companies
From
CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
Tags
Companies
Breaking news
Health & Science
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Business
From
CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
August 10, 2023
Tags
Novo Nordisk A/S
Health & Science
Europe Markets
From
CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
US: News
Obesity
Business News
From
CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
August 09, 2023
Tags
Europe News
Drugs
Europe: Top News And Analysis
From
CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
August 08, 2023
Tags
Fox Corp/ Class A
Citizens Financial Group Inc
Market Insider
From
CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
August 08, 2023
Tags
EchoStar Corp
Sagimet Biosciences Inc
Markets
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Weight management
Companies
Health & Science
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Science
From
CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
July 26, 2023
Tags
Eli Lilly and Co
Business
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Mergers
Weight management
Breaking news
From
CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
July 13, 2023
Tags
Diabetes
Breaking News: Politics
Health care industry
From
CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
Tags
Diabetes
Business News
US: News
From
CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
Tags
Insurance industry
Pfizer Inc
Diabetes
From
CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
July 11, 2023
Tags
Iovance Biotherapeutics Inc
Zillow Group Inc
Markets
From
CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
July 10, 2023
Tags
Biotech and Pharmaceuticals
Business News
Novo Nordisk A/S
From
CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
July 05, 2023
Tags
Biotechnology
Health care industry
GE HealthCare Technologies Inc
From
CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
June 30, 2023
Tags
Surgical procedures
Business News
Pharmaceuticals
From
CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
June 28, 2023
Tags
Weight management
Health & Science
Companies
From
CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
June 26, 2023
Tags
Health care industry
Biotechnology
Health & Science
From
CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
June 26, 2023
Tags
Business
Eli Lilly and Co
Science
From
CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
June 26, 2023
Tags
Pfizer Inc
Health care industry
Biotechnology
From
CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
June 20, 2023
Tickers
LAW
LAWS
Tags
Business News
Companies
Health & Science
From
CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
Tags
Health & Science
Companies
Business
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.